The AMR Conference has become one of the leading international platforms dedicated to confronting the critical global health threat of antimicrobial resistance (AMR). Over the past decade, this essential event has created a vital convergence point for the entire ecosystem, bringing together SMEs, start-ups, big pharma, academia, investors, and public institutions. Its core mission is to collaboratively explore strategies and address the complex, real-world hurdles involved in advancing novel antimicrobial treatments and diagnostics into the market.

True to its mandate, the conference delivers comprehensive and cutting-edge insights across the full innovation value chain. This scope spans everything from early scientific discoveries and preclinical research through to clinical development, financing models, and strategies for sustainable market access. Dedicated tracks explore crucial non-scientific areas like public funding for R&D, manufacturing, and investor perspectives, delivered through high-level keynotes and expert panels. The 2026 edition marks a special 10th anniversary, underscoring the growing relevance and urgency of the AMR challenge while celebrating a decade of collaborative progress.

Beyond the formal program, the event thrives on its vibrant, collaborative atmosphere, with one-to-one partnering remaining at the heart of the experience. This focus on networking provides an invaluable space to build meaningful connections, which is essential for translating research into patient solutions. Highlights include a dynamic start-up pitch and a diverse poster exhibition. The conference is jointly organized by the BEAM Alliance, which advocates for European biotech SMEs developing AMR solutions, and bamconn GmbH, an experienced event management agency specializing in life sciences.